CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 139 enrolled
Drug / intervention
Long-acting insulin glargine titration web tool (LTHome) +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02540486
NCT02540486N/ACompleted
CompareCT.gov

A 12 Week, Parallel, Open-label, Randomized, Multi-center Study Evaluating Use, Safety and Effectiveness of a Web Based Tool vs. Enhanced Usual Therapy of Glargine Titration in T2DM Patients With a 4 Week Safety Extension

LMC Diabetes & Endocrinology Ltd.·interventional·Posted Sep 4, 2015·Updated Sep 4, 2015

In Brief

A clinical study evaluating Long-acting insulin glargine titration web tool (LTHome) and Diabetes Education for Type 2 Diabetes Mellitus. Completed, enrolled 139 participants across 1 site.

Detailed Summary

Evaluating patients with type 2 diabetes either starting once daily basal insulin or requiring increased basal titrations in order to compare the LTHome web based tool with the usual standard of practice for insulin glargine dosing adjustment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes Mellitus
CountriesCanada
CollaboratorsSanofi

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedSep 4, 2015
Enrollment StartDec 1, 2013
Primary CompletionMar 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 10.8 years ago

Interventions

Long-acting insulin glargine titration web tool (LTHome)other

The LTHome study arm will receive insulin glargine titration instructions from the LTHome web-based tool

Diabetes Educationother

Individual diabetes education, detailed instructions on the use of the blood glucose monitor and unlimited availability of blood glucose monitoring supplies.